Macrogenics (MGNX) Interest Coverage Ratio (2023 - 2026)

Macrogenics (MGNX) reported Interest Coverage Ratio of 6.84 for Q1 2026, up 98.54% year-over-year from 3.44 in Q1 2025, and down 141.54% quarter-over-quarter from 2.83 in Q4 2025.

Macrogenics (MGNX) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

Macrogenics (MGNX) has 4 years of Interest Coverage Ratio data on file, last reported at 6.84 in Q1 2026.

  • Interest Coverage Ratio for Q1 2026 came in at 6.84, up 98.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.78 (up 99.65% YoY), and the FY2025 annual result was 8.56, up 91.37% from the prior year.
  • Interest Coverage Ratio declined to 6.84 in Q1 2026 per MGNX's latest filing, from 2.83 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 2201.54 in Q4 2024 and troughed at 9696.83 in Q2 2024.
  • A 4-year average of 817.77 and a median of 46.64 in 2024 frame the typical range for Interest Coverage Ratio.
  • The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 16592.65% in 2024, then jumped 99.53% in 2025.
  • A 4-year view of Interest Coverage Ratio shows it stood at 58.09 in 2023, then surged by 3889.85% to 2201.54 in 2024, then slumped by 100.13% to 2.83 in 2025, then slumped by 141.54% to 6.84 in 2026.
  • Business Quant data shows MGNX's Interest Coverage Ratio at 6.84 in Q1 2026, 2.83 in Q4 2025, and 5.58 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 Macrogenics 260.14 Mn 193.63 Mn - -6.84

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.84
Dec 31, 2025 -2.83
Sep 30, 2025 5.58
Jun 30, 2025 -45.83
Mar 31, 2025 -468.40
Dec 31, 2024 2,201.54
Jun 30, 2024 -9,696.83
Mar 31, 2024 -47.44
Jun 30, 2023 -58.09
Mar 31, 2023 -58.58